Why is the Brainchip share price tumbling 7% on Thursday?

This semiconductor company's shares are under pressure again. But why?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Brainchip Holdings Ltd (ASX: BRN) share price has returned from its trading halt on Thursday.

In morning trade, the semiconductor company's shares are down 7.5% to 18.5 cents.

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.

Image source: Getty Images

Why is the Brainchip share price sinking?

Investors have been selling down the company's shares this morning for a couple of reasons.

One is the announcement of a capital raising and the other is the release of its quarterly update.

In respect to the former, Brainchip has announced a $25 million equity capital raising. This comprises a fully underwritten institutional placement to raise approximately $20 million, a fully underwritten sale of existing securities from LDA Capital, and a non-underwritten share purchase plan (SPP).

These funds will be raised at 19.3 cents per new share, which is a surprisingly modest 3.5% discount to where the Brainchip share price last traded.

According to the release, proceeds from the equity capital raising will be used to support the commercialisation of the company's Akida 2.0 technology and the development, commercialisation and productisation of its new TENNs product.

It believes the latter represents the next evolution in its product portfolio and builds on its existing position in neuromorphic technology.

Commenting on the equity raising, the company's under fire CEO, Sean Hehir, said:

I am very pleased with the outcome from this capital raise, which will allow BrainChip to continue its efforts to bring Akida 2.0 to market as well as develop new products based on our TENNs algorithm that will compliment and accentuate the strengths in our core Akida technology. We are also very pleased to have received the support of a number of quality Australian institutional investors, and to be able to offer our retail investors the opportunity to invest on the same terms through the SPP. At our AGM in May, shareholders made it clear they wanted us to consider adding an SPP into any future capital raise. We heard that message loud and clear, and we have added an SPP into this placement precisely for that reason.

Quarterly update

It was another bitterly disappointing quarter for the company in respect to cash receipts.

Brainchip reported less cash receipts than a Boost Juice stand for the three months, pulling in just US$48,000. This was despite spending over US$3.9 million on operating activities during the period.

Management blamed its long sales cycle times and once again "remains optimistic based on the number of active engagements and level of interest from our prospective customers."

The Brainchip share price is down 48% since this time last year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

It was a veritable party on the ASX today.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ASX board.
Share Market News

ASX 200 charges higher again as relief rally gathers pace

The ASX 200 keeps climbing as global tensions begin to ease.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Dateline, Karoon Energy, Lindian, and PEXA shares are falling today

These shares are missing out on the good times on Wednesday. But why?

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Arafura Rare Earths, Eagers Automotive, Life360, and Pro Medicus shares are racing higher today

These shares are having a good session on hump day. But why?

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Share Fallers

These were the worst-performing ASX 200 shares in March

These shares were out of form in March. Let's see why investors sold them off.

Read more »